Call us 24/7


Precision medicine

New research

Offering clinical trials on new and emerging cancer treatment options.

View our clinical trials

What’s your risk?

Take our cancer risk management questionnaire to help assess your risk and take control.

Assess your cancer risk

Insurance plans

We accept a wide range of insurance plans.

Verify your insurance

Understanding precision cancer care and the options available often requires navigating new and complex information. The precision medicine experts, genetic counselors and supportive care clinicians at Cancer Treatment Centers of America® (CTCA), are available to explain what you can expect from a genetics or genomic test, how that information may be used in developing a treatment or prevention plan and whether a clinical trial may be a viable option. Also, as part of our comprehensive approach to cancer treatment, we have a panel of experts, called a molecular tumor board, who meet regularly to share information and ideas on how to treat each patient's disease. These experts collaborate on a treatment plan personalized to fit the patient’s needs, monitoring the patient’s progress throughout treatment and making adjustments when necessary.

Because precision medicine is a rapidly developing area of medical science, advanced genomic tests and innovative treatments like targeted therapy and immunotherapy should be considered after thorough discussions between the physician and patient and based on each patient’s unique situation.

Our services

Advanced genomic testing

At CTCA®, we use the tools of precision medicine to identify what makes a particular cancer behave the way it does. For some patients, that may include an advanced genomic test, which may uncover mutations that may be matched with targeted treatment options.

Learn more about advanced genomic testing

Genetic testing

Genetic testing may help determine if a patient was born with a higher risk of developing cancer due to an inherited gene mutation. Being diagnosed with a hereditary condition may empower patients to make more informed decisions about how to manage their cancer risks.

Learn more about genetic testing

Genetic counseling

If you know or suspect you have a genetic mutation that may increase your cancer risk, you may consider genetic counseling. Our genetic counselors help educate patients about strategies to help reduce cancer risk and/or increase the chances of catching cancer in its early stages.

Learn more about genetic counseling

Targeted therapy

Targeted therapy drugs may be recommended to treat certain cancers based on the results of an advanced genomic test. These drugs are designed to seek out features unique to cancer cells and target specific proteins or mutations that may be driving the cancer's growth.

Learn more about targeted therapy


Researchers have developed a series of immunotherapy drugs called checkpoint inhibitors designed to energize the body's immune system to better recognize and attack cancer cells. These drugs are designed to expose cancer cells as invaders, triggering an immune response.

Learn more about immunotherapy

Supportive care

We offer evidence-informed supportive care therapies, such as nutritional therapy and mind-body medicine, to help patients maintain the strength to get through treatment. We also offer counseling, spiritual support and other therapies to help patients cope with anxiety and stress.

Learn more about our supportive care services

"Today, with my CTCA care team by my side, I am more hopeful than ever about the road ahead. The genomic testing performed at CTCA assisted my doctors in prescribing the appropriate medication, and I will continue to take it for as long as I can."

Christine Bray

Christine B.

Ovarian Cancer



Clinical trials

CTCA is committed to bringing our patients innovative cancer treatment options. Our clinical trials explore treatment options that may lead to tomorrow’s medicine and offer patients treatments that may not otherwise be available to them. These studies are an essential testing ground for measuring the safety, effectiveness and potential side effects of drugs and other treatments before they can be granted government approval.

One of these clinical trials is the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Led by the American Society of Clinical Oncology (ASCO) and offered at all five CTCA hospitals, the study aims to improve our understanding of how commercially available anti-cancer drugs perform on a broader range of cancers, by matching the drugs to tumors with specific genomic mutations that the drugs are designed to target. This study, like other clinical trials, is not available to or appropriate for all patients. Your care team will work with you to determine whether you are a candidate for TAPUR or one of our other ongoing clinical trials.